Mahajan, U. M., Oehrle, B., Sirtl, S., Alnatsha, A., Goni, E., Regel, I., . . . Mayerle, J. (2022). Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gastroenterology, 163(5), . https://doi.org/10.1053/j.gastro.2022.07.047
Chicago Style (17th ed.) CitationMahajan, Ujwal Mukund, et al. "Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma from Chronic Pancreatitis." Gastroenterology 163, no. 5 (2022). https://doi.org/10.1053/j.gastro.2022.07.047.
MLA (9th ed.) CitationMahajan, Ujwal Mukund, et al. "Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma from Chronic Pancreatitis." Gastroenterology, vol. 163, no. 5, 2022, https://doi.org/10.1053/j.gastro.2022.07.047.